C. Y. Gregory-Evans, Ph.D., T.D.

Current Appointment

Associate Professor in Ophthalmology

Department Ophthalmology and Visual Sciences
University of British Columbia Eye Care Centre
2550 Willow Street
Vancouver, BC, CANADA. V5Z3N9

Office Tel number: 604-875-5529
Lab Tel number: 604-875-4111 x 20550
Fax number: 604-875-4663.
Email: cge30@mail.ubc.ca

 

 

Previous Appointments

2005-2009   Senior Lecturer
Imperial College London, London UK.
1997-2004   Lecturer
Imperial College London, London UK.
1992-1996   Wellcome Trust Research Fellow, Institute of Ophthalmology
University College London, London, UK.
1989-1991   Visiting Post-doctoral Fellow
Jules Stein Eye Institute, UCLA, Los Angeles, USA.

RESEARCH INTERESTS

Tissue fusion during development

Tissue fusion is a recurring event in mammalian embryology, playing a fundamental role for instance in the development of the neural tube, palate and the optic fissure. Most epithelial fusion events involve alignment of two sheets of tissue, such that they can be zippered together to generate a continuous layer. Molecular players are being identified for each step during tissue fusion providing a framework for understanding the regulation of this process at the molecular level. Furthermore, genetic studies have shown that gene defects causing failure of fusion in one location is often associated with failure of fusion in multiple tissues, thereby implying a subset of common mediators of fusion. We are studying optic fissure closure as a model system for epithelial fusion. Fusion defects lead to ocular coloboma which can damage the uveal tract, retina or optic nerve.

Mutation of PAX2 in humans and zebrafish eye cause ocular coloboma due to failure of optic fissure closure. Expression of Rip1 demonstrates activation of the necroptosis cell death pathway in the mutant zebrafish eye which is inhibited by a small drug molecule Necrostatin-1 (nec-1).   Nec-1 inhibits necroptosis and allows closure of the optic fissure ( Viringipurampeer IA et al, 2012. Hum Mol Genet . 21:2357-2369 ).

 

 

Aniridia

Aniridia is a pan-ocular condition characterized by an under-development of the iris tissue (hypoplasia) associated with cataract, Peters' anomaly, corneal disease and foveal hypoplasia. The majority of cases are caused by heterozygous genetic abnormalities affecting the PAX6 gene. We are interested in determining the precise signaling pathways that regulate normal iris development and why it goes wrong in aniridia. The critical questions to be addressed are: (i) what are the genes downstream of PAX6 that are crucial to iris development; (ii) what genes control normal foveal development.

The normal foveal depression and thickening of the outer nuclear layer (ONL) in the adult eye is absent in most cases of aniridia (A). The foveal depression is present at birth however, migration of cones to the foveal region is not complete until the 4-5 year of age (B). The absence of a developed foveal region of the retina results in poor visual acuity and colour vision deficits in patients with aniridia ( Gregory-Evans K et al, 2011. Can J Ophthalmol . 46:337-344 ).

 


KEY PUBLICATIONS

  1. Viringipurampeer IA, Ferreira T, DeMaria S, Moosajee M, Gregory-Evans K, Ngai J, Gregory-Evans CY. Pax2 regulates a Fadd -dependent cellular switch that drives tissue fusion during eye development. Hum. Mol. Genet. 2012; 21:2357-2369.
  2. Gregory-Evans CY, Moosajee M, Shan X, Gregory-Evans K. Gene-specific differential response to anti-apoptotic therapies in zebrafish models of ocular coloboma. Mol Vis. 2011;17: 1473-1484.
  3. Gregory-Evans K, Cheong-Leen R, George SM, Xie J, Moosajee M, Colapinto P, Gregory-Evans CY. Non-invasive anterior segment and posterior segment optical coherence tomography and phenotypic characterization of aniridia. Can J Ophthalmol . 2011;46:337-44.  
  4. Xu, XL, Fang Y, Lee TC, Forrest D, Gregory-Evans CY , Almeida D, Liu A, Jhanwar SC, Abramson DH, and Cobrinik D. Retinoblastoma has the properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell 2009;137:1018-31.
  5. Moosajee M, Gregory-Evans K, Ellis CD, Seabra MC, Gregory-Evans CY. Translational bypass of nonsense mutations in zebrafish rep1 , pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet. 2008;17:3987-4000.
  6. Gregory-Evans CY , Vieira H, Dalton R, Adams GGW, Salt A and Gregory-Evans K. Ocular coloboma and high myopia with Hirschsprung disease associated with a novel ZFHX1B missense mutation and trisomy 21. Am J Med Genet . 2004;131A:86-90.
  7. Bibb LC, Holt JKL, Tarttelin EE, Hodges MD, Gregory-Evans K, Lucas RJ, Sowden JC, Gregory-Evans CY . Temporal and spatial expression patterns of the CRX gene and its downstream targets. Critical differences during human and mouse eye development. Hum Mol Genet . 2001;10:1571-1579.
  8. Freund CL, Gregory-Evans CY, Furukawa T, Papaioannou M, Looser J, Ploder L, Bellingham J, Ng D, Herbrick J-AS, Duncan A, Scherer SW, Tsui L-C, Loutradis-Anagnostou A, Cepko CL, Jacobson SG, Bhattacharya SS, McInnes RR. Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene ( CRX ) required for maintenance of the mammalian photoreceptor. Cell 1997;91:543-553.

EXTERNAL RESEARCH FUNDING 1998-2011

Canadian Institute of Health Research
Sharon Stewart Aniridia Trust
The Wellcome Trust
Birth Defects Foundation
Medical Research Council (UK)
Fight for Sight (UK)
Funding for Science and Technology (Portugal)
British Retinitis Pigmentosa Society (UK)
St. Mary's Paddington Charitable Trust (UK)


Home | People | Divisions | Facilities | Education | Patient Care | Outreach | Donations | Contact | Site Map
Return to top

a place of mind, The University of British Columbia

Faculty of Medicine

UBC Department of Ophthalmology & Visual Sciences
Eye Care Centre (VGH)
2550 Willow Street
Vancouver, BC
Canada V5Z 3N9
tel 604-875-4555 | fax 604-875-4663 | e-mail webmaster@eyecarecentre.org

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia